AlzeCure Pharma Gets EUR 2.5 Million Grant for Alzheimer’s Drug Study
AlzeCure Pharma has shared exciting news: they’ve received the first part of a EUR 2.5 million grant from the European […]
SciNeuro Pharmaceuticals Raises $53 Million to Develop Drugs for Nerve Diseases
A new company called SciNeuro Pharmaceuticals, started in 2020, announced on Thursday that it has raised $53 million to help
Pharmaceutical News
Bristol Myers Squibb’s Breyanzi Gets Fifth US Approval for Cancer Treatment
The US Food and Drug Administration (FDA) has approved Bristol Myers Squibb’s Breyanzi (Lisocabtagene maraleucel) as a treatment for adults
Measles Deaths Drop, But WHO Warns of Ongoing Risks
The World Health Organization (WHO) has shared some good news: deaths from measles have gone down a lot in recent
Valneva to Close Nantes Facility, Focus on Lyon and Vienna
The French company Valneva, which makes vaccines, has decided to close its facility in Nantes, France. This building is used
Why Eli Lilly’s Success Might Be Tied to Its CEO’s High Employee Approval
Is it just luck that the most valuable pharmaceutical company, Eli Lilly, also has a CEO who is highly rated
Pharmaceutical News
New Method Could Make Drug Manufacturing Safer
A group of researchers have created a new, quick way to check for harmful substances called nitrosamines in the main
New UK Trial Aims to Improve Dementia Diagnosis with Simple Blood Tests
A new study in the UK, called the ‘READ OUT’ trial, is looking into using blood tests to help diagnose
Healthcare Experts Share Key Insights from Recent Conferences
As autumn comes to an end, healthcare experts are busy sharing their knowledge at various conferences before the year concludes.
FDA Introduces New Plan to Speed Up Custom-Made Treatments for Rare Diseases
The U.S. Food and Drug Administration (FDA) has introduced a new plan to help speed up the development of custom-made